Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hodgson

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|April 4, 2023
Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte-predominant Hodgkin lymphoma: an IMPACT cohort studyAngela Punnett, Nancy N Baxter, David Hodgson, et al.
The Lancet Regional Health. Europe|September 23, 2024
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]David Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2022
Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Sarah Alexander, et al.
The Lancet Regional Health. Europe|March 13, 2024
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccinationDavid Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Journal of Cancer Survivorship : Research and Practice|August 9, 2017
Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancerKristin C Marr, Mohammad Agha, Rinku Sutradhar, et al.
Bioscience Reports|January 19, 2017
Modelling the molecular mechanisms of agingMark T Mc Auley, Alvaro Martinez Guimera, David Hodgson, et al.
Journal of Neuro-Oncology|April 3, 2019
Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adultsAndrea C Lo, Normand Laperriere, David Hodgson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicityDavid Hodgson, Stephany Sánchez-Ovando, Louise Carolan, et al.
BMC Medicine|March 10, 2026
Kinetics of antibodies and risk of respiratory syncytial virus infection: a longitudinal cohort in Taizhou City, eastern ChinaQiang Wang, David Hodgson, Bo Zheng, et al.
Vaccine|December 5, 2024
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicityDavid Hodgson, Stephany Sánchez-Ovando, Louise Carolan, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|April 4, 2023
Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte-predominant Hodgkin lymphoma: an IMPACT cohort studyAngela Punnett, Nancy N Baxter, David Hodgson, et al.
The Lancet Regional Health. Europe|September 23, 2024
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]David Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2022
Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Sarah Alexander, et al.
The Lancet Regional Health. Europe|March 13, 2024
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccinationDavid Hodgson, Neil Wilkins, Edwin van Leeuwen, et al.
Journal of Cancer Survivorship : Research and Practice|August 9, 2017
Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancerKristin C Marr, Mohammad Agha, Rinku Sutradhar, et al.
Bioscience Reports|January 19, 2017
Modelling the molecular mechanisms of agingMark T Mc Auley, Alvaro Martinez Guimera, David Hodgson, et al.
Journal of Neuro-Oncology|April 3, 2019
Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adultsAndrea C Lo, Normand Laperriere, David Hodgson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicityDavid Hodgson, Stephany Sánchez-Ovando, Louise Carolan, et al.
BMC Medicine|March 10, 2026
Kinetics of antibodies and risk of respiratory syncytial virus infection: a longitudinal cohort in Taizhou City, eastern ChinaQiang Wang, David Hodgson, Bo Zheng, et al.
Vaccine|December 5, 2024
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicityDavid Hodgson, Stephany Sánchez-Ovando, Louise Carolan, et al.
Pageof 18